Revised STED form up consultation:
This article was originally published in Clinica
Study Group 1 of the Global Harmonization Task Force (GHTF) is seeking comments on its revised document on Summary Technical Documentaion for Demonstrating Conformity to the Essential Principles of Safety and Performance of Medical Devices (STED). The document title is SG1/N011R17 and the proposed revisions are on the website at www.ghtf.org. The group completed revision of this document in March month and the revisions are substantial enough, it says, to warrant public consultation.
You may also be interested in...
Approved in February as an on-demand remedy, Nurtec will be filed for migraine prevention after success in Phase III. It could be the first oral preventive therapy and first dual purpose migraine drug.
A protocol amendment is not needed to pause enrollment to decrease potential exposure to COVID-19, and virtual visits can be immediately implemented to ensure safety; experts say pandemic is forcing a rethinking in how companies carry out trials and in how regulators ensure patient safety and trial integrity.
South Korea’s Qurient achieves proof of concept in a Phase II study with its first-in-class antibiotic telacebec for tuberculosis and aims to file a US NDA for the orphan drug.